A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Choi, MD
University of California, San Diego
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope (city of Hope National Medical Center, City of Hope Medical Center)
Duarte, California, United States
- Sanford Stem Cell Clinical Center at Ucsd
La Jolla, California, United States
- Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Louisiana State University Health New Orleans (nci Community Oncology Research Program)
New Orleans, Louisiana, United States
- Hackensack Meridian Health, John Theurer Cancer Center
Hackensack, New Jersey, United States
- Northwell Health
New Hyde Park, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Manhattan Hematology Oncology Research Foundation, Inc.
New York, New York, United States
- the Christ Hospital Lindner Research Center
Cincinnati, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jan 2018
- Primary completion
- 25 Sept 2024
- Completion
- 25 Sept 2024
- Last update posted
- 12 Feb 2025
- Registered enrollment
- 95
- Registry id
- NCT03088878
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.